Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cryo-Cell International Inc CCEL

Healthcare Medical Care
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem... see more

Recent & Breaking News (NYSEAM:CCEL)

Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend

Business Wire May 8, 2025

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results

Business Wire April 15, 2025

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024

Business Wire February 28, 2025

Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives

Business Wire January 29, 2025

Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend

Business Wire October 30, 2024

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results

Business Wire October 15, 2024

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results

Business Wire July 15, 2024

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results

Business Wire April 15, 2024

Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

Business Wire March 25, 2024

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

Business Wire February 28, 2024

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results

Business Wire October 12, 2023

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results

Business Wire July 14, 2023

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results

Business Wire April 21, 2023

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022

GlobeNewswire February 28, 2023

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results

GlobeNewswire October 14, 2022

Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend

GlobeNewswire August 22, 2022

Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange

GlobeNewswire August 17, 2022

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results

GlobeNewswire July 11, 2022

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

GlobeNewswire April 13, 2022

Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

GlobeNewswire March 16, 2022